News

Fitbit and FibriCheck, an innovative health screening and monitoring app, announced a partnership enabling users in Belgium, the Netherlands, Ireland, and the UK to monitor their heart rhythm for irregularities, such as atrial fibrillation...

BioTrace Medical, Inc., the leader in innovative temporary pacing technology, announced the company’s key activities at the 31st annual Transcatheter Cardiovascular Therapeutics (TCT) conference, which will take place September 25-29 in San...

Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data on the first human implants of its unique technology for the prevention of stroke in patients with atrial fibrillation (AFib)...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced important new real-world evidence confirming XARELTO® (rivaroxaban) reduced the risk of recurrent venous thromboembolism (VTE) – or blood clots – in patients who are...

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the WiSE CRT System for the...

The First Class III Medical Device is Certified Under the New European Medical Device Regulation BERLIN, Germany, September 18, 2019 – BIOTRONIK announced that it is the world’s first manufacturer to receive European Medical Device...

Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce it will be exhibiting and presenting two posters at the 2019 Safety Pharmacology Society Annual Meeting (SPS), September 23–26 at the Centre...

ARCA biopharma, Inc. (ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced that Gencaro atrial fibrillation clinical data from the...